CWM
LYEL icon

CIBC World Markets’s Lyell Immunopharma LYEL Stock Holding History

CIBC World Markets’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,783
Closed -$19.2K – 1773
2025
Q1 		$19.2K Buy
1,783
+1,031
+137% +$12.6K ﹤0.01% 1797
2024
Q4 		$9.63K Buy
+752
New +$14.9K ﹤0.01% 1319

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIBC World Markets's LYEL Position: Q2 2025 in Review

CIBC World Markets sold out of Lyell Immunopharma (LYEL) in Q2 2025, closing a stake of 1,783 shares — an estimated $19.2K sold.

CIBC World Markets first reported a position in LYEL in Q4 2024 and held it in 2 quarters. The position peaked at $19.2K in Q1 2025. 69 funds tracked by Wall St. Rank hold LYEL as of Q2 2025.

  • CIBC World Markets reported no remaining Lyell Immunopharma position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 1,783 Lyell Immunopharma shares in Q2 2025, an estimated $19.2K.
  • CIBC World Markets first reported a position in Lyell Immunopharma in Q4 2024 and held it in 2 quarters.
  • CIBC World Markets's Lyell Immunopharma position peaked at $19.2K in Q1 2025.
  • 69 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.